News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Wungki Park: Probably most meaningful ASCO in my 14 year membership
Photo taken from Wungki Park/X
Jun 6, 2024, 12:36

Wungki Park: Probably most meaningful ASCO in my 14 year membership

Wungki Park, Gastrointestinal Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X:

“Happy moments. Can’t have ASCO without MORE friends! ASCO24 thank you all of you for your support!!! Probably most meaningful ASCO in my 14 year membership for ASCO. See you again at ASCO25.”

Wungki Park

Source: Wungki Park/X

ASCO24 cancer OncoDaily Oncology Wungki Park
Special Coverage
Blog
Jan 16, 2025, 07:14
Remembering Amy Babler: A fearless Advocate for Cancer Awareness and Communications
Insight
Jan 16, 2025, 07:08
Predictive Oncology has Announced Agreement to be Acquired by Renovaro
Blog
Jan 16, 2025, 06:30
Senthil Kumar: Management of Advanced/Metastatic Gastrointestinal Stromal Tumor
Blog
Jan 16, 2025, 06:09
Manoj Reddy: IOWG Grand Rounds
Blog
Jan 16, 2025, 06:00
Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer
Career
Jan 16, 2025, 05:58
Miguel Pereira-Silva: Happy to announce my new position as a Postdoctoral Scientist at MD Anderson Cancer Center
Blog
Jan 16, 2025, 05:53
Massimiliano Camilli: Submit your valuable science to ECS Cardio Oncology 2025
Dialogues
Jan 15, 2025, 21:45
Next-Generation Sequencing and Targets in Early-Phase Colorectal Cancer Drug Development
Insight
Jan 15, 2025, 18:32
MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening
Insight
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Blog
Jan 15, 2025, 18:25
Discussion on advancing the Global Cancer Fund at The White House - ASCO
Blog
Jan 15, 2025, 18:19
Antonio Passaro: COCOON study meets primary endpoint